Dilantin Extended Phenytoin Sodium 100 mg Capsule, 100-count — NDC 0071-0369-40 (Billing 00071-0369-40)
This is a package of 100 capsules of Dilantin Extended Phenytoin Sodium 100 mg Capsule from Parke-Davis Div of Pfizer Inc, no longer marketed, no longer in the FDA NDC Directory; retail pharmacies pay about $1.66 per capsule (NADAC).
NDC database record
One package, one record: these facts belong to NDC 0071-0369-40 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 0071 labeler · 0369 product · 40 package
- Billing quantity
- 100 EA per package
- Barcode (UPC-A, from the NDC)
- 3 0071036940 5
- FDA record last changed
- Mar 13, 2024
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 004521
- GCN: 17700
- HICL (First Databank): 001877
- AHFS class code: 24:04.04.08
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 19, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats seizures. Depending on the product, that includes grand mal seizures, temporal lobe or complex partial seizures, and seizures during or after brain surgery. The injection...
- No. Stopping suddenly can trigger a dangerous, prolonged seizure. If you need to reduce or stop it, your prescriber will do it gradually.
- The most common are unsteadiness, eye movements, slurred speech, sleepiness and confusion. These are often dose-related, so tell your doctor if they appear. Call right away for a r...
- Yes. Phenytoin interacts with many drugs, including antacids, antifungals, warfarin, blood thinners and birth control. Tell me or your doctor about everything you take, including S...
Patient education
Drug interactions
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 19, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $1.659 | $165.94 / 100 capsule |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file · file of Nov 26, 2025
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Marketing end | Status |
|---|---|---|---|---|---|---|
| 00071-0369-24 0071-0369-24 Main listing | 100 CAPSULE in 1 BOTTLE | $1.74 / ea | $174.20 | 1976-08-27 | — | Discontinued by firm |
| 00071-0369-32 0071-0369-32 | 1000 CAPSULE in 1 BOTTLE | $1.74 / ea | $1,742.03 | 1976-08-27 | — | Discontinued by firm |
| 00071-0369-40 You're viewing this | 100 BLISTER PACK in 1 CARTON / 1 CAPSULE in 1 BLISTER PACK | $1.66 / ea | $165.94 | 1976-08-27 | — | Discontinued by firm |
This pack has the lowest per-ea cost of the 3 priced pack sizes ($1.66 NADAC).
This pack accounts for about 0.9% of this product's recent Medicaid fills; most go to the 100 capsules pack. See all packs ↓
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 00071-0369-24?
What NDC number is used to bill for this package of Dilantin Extended Phenytoin Sodium 100 mg Capsule?
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Phenytoin Sodium 100 mg 00904-7416-61 | Major | 1 capsule | $0.144 | AB | Availability likely | save 91% |
| Phenytoin Sodium 100 mg 50268-0719-13 | AvPAK | 1 capsule | $0.144 | AB | Availability likely | save 91% |
| Extended Phenytoin Sodium 100 mg 60687-0841-01 | American | 100 capsules | $0.144 | AB | Availability likely | save 91% |
| Phenytoin Sodium 100 mg 65862-0692-01 | Aurobindo | 100 capsules | $0.144 | — | Availability likely | save 91% |
| Dilantin 100 mgthis 00071-0369-40 | Parke-Davis | 100 capsules | $1.659 | — | Discontinued | — |
| Dilantin 100 mg 58151-0110-01 | Viatris | 100 capsules | $1.738 | AB | Availability likely | +5% |
| Extended Phenytoin Sodium 100 mg 00615-8556-39 | NCS | 30 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 29300-0379-01 | Unichem | 100 capsules | — | — | FDA listed | — |
| Phenytoin Sodium 100 mg 50090-3539-00 | A-S | 100 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 50090-5700-00 | A-S | 100 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 51407-0982-01 | Golden | 100 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 51672-4111-00 | Sun | 10 capsules | — | AB | Discontinued | — |
| Phenytoin Sodium 100 mg 61919-0815-30 | DIRECT | 30 capsules | — | AB | FDA listed | — |
| Extended Phenytoin Sodium 100 mg 65162-0212-03 | Amneal | 30 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 67046-0585-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 70518-0107-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Extended Phenytoin Sodium 100 mg 70518-2227-00 | REMEDYREPACK | 30 capsules | — | AB | Discontinued | — |
| Phenytoin Sodium 100 mg 70518-2293-01 | REMEDYREPACK | 1 capsule | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 71610-0869-92 | Aphena | 270 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 71610-0934-92 | Aphena | 270 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 72162-1646-00 | Bryant | 1000 capsules | — | AB | Discontinued | — |
| Extended Phenytoin Sodium 100 mg 72162-2514-00 | Bryant | 1000 capsules | — | AB | FDA listed | — |
| Phenytoin Sodium 100 mg 82804-0269-72 | Proficient | 120 capsules | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file · file of Nov 26, 2025
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Phenytoin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 19, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Parke-Davis Div of Pfizer Inc labeler code 00071
- Dilantin Infatabs Phenytoin 50 mg Tablet, Chewable NDC 0071-0007-24
- Zarontin Ethosuximide 250 mg Capsule NDC 0071-0237-24
- Nardil Phenelzine Sulfate 15 mg Tablet, Film Coated NDC 0071-0350-60
- Neurontin gabapentin 800 mg Tablet, Film Coated NDC 0071-0401-24
- Neurontin gabapentin 600 mg Tablet, Film Coated NDC 0071-0513-24
- Celontin methsuximide 300 mg Capsule NDC 0071-0525-24
- Lopid gemfibrozil 600 mg Tablet, Film Coated NDC 0071-0737-20
- Neurontin gabapentin 100 mg Capsule NDC 0071-0803-24
- Neurontin gabapentin 300 mg Capsule NDC 0071-0805-24
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicaid utilization by pack size
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC The FDA label for this product carries no photos. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |